XERS ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/6/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-0.18
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)92.10M
Xeris Biopharma Holdings Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Xeris Biopharma Holdings Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Xeris Biopharma Holdings Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Xeris Biopharma Holdings Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Xeris Biopharma Holdings Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
XERS ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
XERS FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)0.00100.92%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)291.85M43.72%
Xeris Biopharma Holdings Inc(XERS) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/6/2026 | 06/2026 | -0.18/0.00 | 92.10M/90.22M | -5504.20% | 2.08% |
| 5/7/2026 | 03/2026 | 0.01/-0.01 | 83.13M/79.99M | 257.26% | 3.92% |
| 3/2/2026 | 12/2025 | 0.07/0.04 | 85.81M/82.34M | 51.68% | 4.21% |
| 11/6/2025 | 09/2025 | 0.00/0.00 | 74.38M/74.18M | -5.25% | 0.27% |
| 8/7/2025 | 06/2025 | -0.01/-0.03 | 71.54M/64.58M | 56.04% | 10.78% |
| 5/8/2025 | 03/2025 | -0.06/-0.05 | 60.12M/57.61M | -13.41% | 4.36% |
| 3/6/2025 | 12/2024 | -0.03/-0.06 | 60.10M/58.10M | 45.89% | 3.43% |
| 11/8/2024 | 09/2024 | -0.11/-0.09 | 54.27M/51.43M | -17.37% | 5.51% |